Related Experiment Video
Updated: Mar 6, 2026

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Hepatic mitochondrial DNA/Toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil
Yong He1,2,3, Dechun Feng2, Man Li2
1School of Pharmacy, Anhui Medical University, Hefei, China.
Abstract:
Acetaminophen (APAP) overdose is a leading cause of acute liver failure worldwide, in which mitochondrial DNA (mtDNA) released by damaged hepatocytes activates neutrophils through binding of Toll-like receptor 9 (TLR9), further aggravating liver injury. Here, we demonstrated that mtDNA/TLR9 also activates a negative feedback pathway through induction of microRNA-223 (miR-223) to limit neutrophil overactivation and liver injury. After injection of APAP in mice, levels of miR-223, the most abundant miRNAs in neutrophils, were highly elevated in neutrophils. Disruption of the miR-223 gene exacerbated APAP-induced hepatic neutrophil infiltration, oxidative stress, and injury and enhanced TLR9 ligand-mediated activation of proinflammatory mediators in neutrophils. An additional deletion of the intercellular adhesion molecule 1 (ICAM-1) gene ameliorated APAP-induced neutrophil infiltration and liver injury in miR-223 knockout mice. In vitro experiments revealed that miR-223-deficient neutrophils were more susceptible to TLR9 agonist-mediated induction of proinflammatory mediators and nuclear factor kappa B (NF-κB) signaling, whereas overexpression of miR-223 attenuated these effects in neutrophils. Moreover, inhibition of TLR9 signaling by either treatment with a TLR9 inhibitor or by disruption of TLR9 gene partially, but significantly, suppressed miR-223 expression in neutrophils post-APAP injection. In contrast, activation of TLR9 up-regulated miR-223 expression in neutrophils in vivo and in vitro. Mechanistically, activation of TLR9 up-regulated miR-223 by enhancing NF-κB binding on miR-223 promoter, whereas miR-223 attenuated TLR9/NF-κB-mediated inflammation by targeting IκB kinase α expression. Collectively, up-regulation of miR-223 plays a key role in terminating the acute neutrophilic response and is a therapeutic target for treatment of APAP-induced liver failure. (Hepatology 2017;66:220-234).
Insights
MicroRNA-223 (miR-223) limits liver injury from acetaminophen overdose by reducing neutrophil overactivation. Upregulating miR-223 offers a therapeutic strategy for acute liver failure.
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Acetaminophen (APAP) overdose causes acute liver failure, with mitochondrial DNA (mtDNA) activating neutrophils via Toll-like receptor 9 (TLR9).
- This neutrophil activation exacerbates liver injury, highlighting a need to understand regulatory mechanisms.
Purpose of the Study:
- To investigate the role of microRNA-223 (miR-223) in regulating neutrophil response during APAP-induced liver injury.
- To elucidate the molecular mechanisms linking mtDNA/TLR9 signaling to miR-223 expression and its downstream effects.
Main Methods:
- Acetaminophen overdose model in mice with gene disruption of miR-223 and ICAM-1.
- In vitro studies using neutrophils stimulated with TLR9 agonists.
- Analysis of inflammatory mediators, NF-κB signaling, and gene expression.
Main Results:
- miR-223 levels were significantly elevated in neutrophils after APAP overdose.
- Loss of miR-223 exacerbated APAP-induced liver injury, neutrophil infiltration, and oxidative stress.
- miR-223 deficiency enhanced TLR9-mediated inflammatory responses in neutrophils, while miR-223 overexpression attenuated them.
- TLR9 activation upregulated miR-223 expression via NF-κB, and miR-223 targeted IκB kinase α to suppress inflammation.
Conclusions:
- Upregulation of miR-223 is a critical negative feedback mechanism terminating neutrophilic responses in APAP-induced liver injury.
- miR-223 acts as a crucial regulator of neutrophil activation and inflammation.
- Targeting miR-223 presents a potential therapeutic strategy for treating acetaminophen-induced acute liver failure.
More Related Videos
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Dose-Dependent Reactions

